Twamley SG, Stach A, Heilmann H, Shl-Kielczynski B, Stangl V, Ludwig A, Mnster-Wandowski A
Patients who pair them with sleep, protein, and training see the biggest shift same pattern we see with NAD+ IV therapy
Lincoff AM, Botros J, Wolski K, et al
A recent retrospective analysis of nearly 2 million people on these drugs, reported 9-fold increase in the risk of pancreatitis, a 4-fold increase in bowel obstruction, a 3-fold increase in paralysis of the gastric stomach (gastroparesis) and a significant increase in getting gall stones or an inflamed gall bladder
The catch: they must have stock available
Oral GLP-1 Receptor Agonists The expansion of GLP-1 agonists into oral formulations holds substantial market promise